2023
DOI: 10.1016/j.compositesb.2022.110428
|View full text |Cite
|
Sign up to set email alerts
|

Advances in the antimicrobial treatment of osteomyelitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(11 citation statements)
references
References 287 publications
0
11
0
Order By: Relevance
“…A study employing HAp as a carrier loaded with ciprofloxacin demonstrated notable antimicrobial activity, effectively enhancing the proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells [ 54 ]. Commonly utilized antibiotics for bone infection therapy include gentamicin, vancomycin, and zyvox (linezolid) [ 55 ].…”
Section: Introductionmentioning
confidence: 99%
“…A study employing HAp as a carrier loaded with ciprofloxacin demonstrated notable antimicrobial activity, effectively enhancing the proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells [ 54 ]. Commonly utilized antibiotics for bone infection therapy include gentamicin, vancomycin, and zyvox (linezolid) [ 55 ].…”
Section: Introductionmentioning
confidence: 99%
“…Surgical debridement and antibiotic treatment are the most conventional clinical approaches to treat bacterial infection. [ 46 ] In particular, surgical debridement is an effective method to treat bacterial infections that mainly involve biofilm infection or subcutaneous abscesses caused by bacterial infection. However, surgical debridement is not effective for bacterial infection treatment because the bacteria are small and easily remain.…”
Section: Current Clinical Strategiesmentioning
confidence: 99%
“…At the site of infection, pathogens can produce bacterial toxins that severely damage blood vessels and bone tissue, preventing antibiotics from penetrating the infected area and accelerating bone destruction [ 7 ]. In recent years, various materials used in the treatment of osteomyelitis have achieved satisfactory results [ 8 , 9 ], but there are still some deficiencies, such as secondary injury of material removal, metabolic toxicity of material in vivo, and its specific molecular mechanism is unknown. Nanoparticles are designed as nanoscale (1–100 ​nm) synthetic building blocks for drug delivery, construct scaffold to fill the repair promoting factor and other medical applications [ 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%